Structure, Functions and Selective Inhibitors of HDAC6

Author(s): Tao Liang, Hao Fang*

Journal Name: Current Topics in Medicinal Chemistry

Volume 18 , Issue 28 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Histone deacetylases 6 (HDAC6) has emerged as a promising target for the treatment of various human diseases including cancer, neurodegenerative disease and immunology due to its unique structure, substrate and biological functions. HDAC6 is involved in cell motility, cell survival, cell cycle progression, developmental events, prognosis as well as protein degradation and the involvement of HDAC6 in multiple biological processes has gained lots of attention. There is increasing interest in HDAC6 and its selective inhibitors. More than twenty years of synthetic efforts have developed various HDAC6 selective inhibitors with different Cap, linker and ZBG. This review will summarize recent research data regarding HDAC6 and various HDAC6 selective inhibitors.

Keywords: Epigenetics, HDAC6, Protein degradation, Neurodegenerative disease, Cancer, HDAC6 selective inhibitors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 29 November, 2018
Page: [2429 - 2447]
Pages: 19
DOI: 10.2174/1568026619666181129141822
Price: $65

Article Metrics

PDF: 232
HTML: 28